Nu Skin Enterprises, Inc. (NUS) Stock Competitors & Peer Comparison
See (NUS) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NUS | $5.28 | +0.19% | 256.1M | 4.40 | $1.20 | +4.57% |
| PG | $146.64 | -1.22% | 341.1B | 21.11 | $6.94 | +2.90% |
| UL | $60.12 | -1.76% | 129.4B | 19.76 | $3.04 | +3.78% |
| CL | $91.68 | -0.78% | 73.4B | 24.45 | $3.75 | +2.28% |
| KVUE | $19.11 | +0.21% | 36.7B | 16.47 | $1.16 | +4.35% |
| KMB | $109.77 | -0.13% | 36.4B | 14.50 | $7.57 | +4.63% |
| EL | $78.95 | -0.53% | 28.6B | 35.72 | $2.21 | +1.76% |
| CHD | $96.88 | -1.04% | 22.9B | 27.19 | $3.56 | +1.24% |
| SGI | $78.40 | +0.32% | 16.5B | 28.10 | $2.79 | +0.82% |
| CLX | $95.44 | -1.70% | 11.5B | 14.14 | $6.75 | +5.27% |
Stock Comparison
NUS vs PG Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, PG has a market cap of 341.1B. Regarding current trading prices, NUS is priced at $5.28, while PG trades at $146.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas PG's P/E ratio is 21.11. In terms of profitability, NUS's ROE is +0.07%, compared to PG's ROE of +0.31%. Regarding short-term risk, NUS is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check PG's competition here
NUS vs UL Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, UL has a market cap of 129.4B. Regarding current trading prices, NUS is priced at $5.28, while UL trades at $60.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas UL's P/E ratio is 19.76. In terms of profitability, NUS's ROE is +0.07%, compared to UL's ROE of +0.36%. Regarding short-term risk, NUS is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check UL's competition here
NUS vs CL Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, CL has a market cap of 73.4B. Regarding current trading prices, NUS is priced at $5.28, while CL trades at $91.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas CL's P/E ratio is 24.45. In terms of profitability, NUS's ROE is +0.07%, compared to CL's ROE of +4.75%. Regarding short-term risk, NUS is more volatile compared to CL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check CL's competition here
NUS vs KVUE Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, KVUE has a market cap of 36.7B. Regarding current trading prices, NUS is priced at $5.28, while KVUE trades at $19.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas KVUE's P/E ratio is 16.47. In terms of profitability, NUS's ROE is +0.07%, compared to KVUE's ROE of +0.15%. Regarding short-term risk, NUS is more volatile compared to KVUE. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check KVUE's competition here
NUS vs KMB Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, KMB has a market cap of 36.4B. Regarding current trading prices, NUS is priced at $5.28, while KMB trades at $109.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas KMB's P/E ratio is 14.50. In terms of profitability, NUS's ROE is +0.07%, compared to KMB's ROE of +1.44%. Regarding short-term risk, NUS is more volatile compared to KMB. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check KMB's competition here
NUS vs EL Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, EL has a market cap of 28.6B. Regarding current trading prices, NUS is priced at $5.28, while EL trades at $78.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas EL's P/E ratio is 35.72. In terms of profitability, NUS's ROE is +0.07%, compared to EL's ROE of -0.06%. Regarding short-term risk, NUS is more volatile compared to EL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check EL's competition here
NUS vs CHD Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, CHD has a market cap of 22.9B. Regarding current trading prices, NUS is priced at $5.28, while CHD trades at $96.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas CHD's P/E ratio is 27.19. In terms of profitability, NUS's ROE is +0.07%, compared to CHD's ROE of +0.17%. Regarding short-term risk, NUS is more volatile compared to CHD. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check CHD's competition here
NUS vs SGI Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, SGI has a market cap of 16.5B. Regarding current trading prices, NUS is priced at $5.28, while SGI trades at $78.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas SGI's P/E ratio is 28.10. In terms of profitability, NUS's ROE is +0.07%, compared to SGI's ROE of +0.17%. Regarding short-term risk, NUS is more volatile compared to SGI. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SGI's competition here
NUS vs CLX Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, CLX has a market cap of 11.5B. Regarding current trading prices, NUS is priced at $5.28, while CLX trades at $95.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas CLX's P/E ratio is 14.14. In terms of profitability, NUS's ROE is +0.07%, compared to CLX's ROE of +28.26%. Regarding short-term risk, NUS is less volatile compared to CLX. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check CLX's competition here
NUS vs REYN Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, REYN has a market cap of 5.7B. Regarding current trading prices, NUS is priced at $5.28, while REYN trades at $26.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas REYN's P/E ratio is 15.98. In terms of profitability, NUS's ROE is +0.07%, compared to REYN's ROE of +0.15%. Regarding short-term risk, NUS is more volatile compared to REYN. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check REYN's competition here
NUS vs NTCO Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, NUS is priced at $5.28, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas NTCO's P/E ratio is -11.37. In terms of profitability, NUS's ROE is +0.07%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, NUS is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check NTCO's competition here
NUS vs ELF Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, ELF has a market cap of 4.4B. Regarding current trading prices, NUS is priced at $5.28, while ELF trades at $74.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas ELF's P/E ratio is 23.63. In terms of profitability, NUS's ROE is +0.07%, compared to ELF's ROE of +0.02%. Regarding short-term risk, NUS is less volatile compared to ELF. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check ELF's competition here
NUS vs IPAR Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, IPAR has a market cap of 3.6B. Regarding current trading prices, NUS is priced at $5.28, while IPAR trades at $111.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas IPAR's P/E ratio is 21.23. In terms of profitability, NUS's ROE is +0.07%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, NUS is less volatile compared to IPAR. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check IPAR's competition here
NUS vs NWL Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, NWL has a market cap of 2.6B. Regarding current trading prices, NUS is priced at $5.28, while NWL trades at $6.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas NWL's P/E ratio is 11.37. In terms of profitability, NUS's ROE is +0.07%, compared to NWL's ROE of -0.11%. Regarding short-term risk, NUS is more volatile compared to NWL. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check NWL's competition here
NUS vs SPB Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, SPB has a market cap of 2B. Regarding current trading prices, NUS is priced at $5.28, while SPB trades at $85.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas SPB's P/E ratio is 13.19. In terms of profitability, NUS's ROE is +0.07%, compared to SPB's ROE of +0.07%. Regarding short-term risk, NUS is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SPB's competition here
NUS vs COTY Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, COTY has a market cap of 1.9B. Regarding current trading prices, NUS is priced at $5.28, while COTY trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas COTY's P/E ratio is 12.03. In terms of profitability, NUS's ROE is +0.07%, compared to COTY's ROE of -0.15%. Regarding short-term risk, NUS is less volatile compared to COTY. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check COTY's competition here
NUS vs EPC Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, EPC has a market cap of 1.2B. Regarding current trading prices, NUS is priced at $5.28, while EPC trades at $26.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas EPC's P/E ratio is 13.16. In terms of profitability, NUS's ROE is +0.07%, compared to EPC's ROE of -0.05%. Regarding short-term risk, NUS is more volatile compared to EPC. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check EPC's competition here
NUS vs HELE Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, HELE has a market cap of 677.1M. Regarding current trading prices, NUS is priced at $5.28, while HELE trades at $29.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas HELE's P/E ratio is 8.21. In terms of profitability, NUS's ROE is +0.07%, compared to HELE's ROE of -0.95%. Regarding short-term risk, NUS is less volatile compared to HELE. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check HELE's competition here
NUS vs EWCZ Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, NUS is priced at $5.28, while EWCZ trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, NUS's ROE is +0.07%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, NUS is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check EWCZ's competition here
NUS vs PTNM Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, NUS is priced at $5.28, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas PTNM's P/E ratio is 346.33. In terms of profitability, NUS's ROE is +0.07%, compared to PTNM's ROE of -0.05%. Regarding short-term risk, NUS is more volatile compared to PTNM. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check PTNM's competition here
NUS vs ACU Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, ACU has a market cap of 184M. Regarding current trading prices, NUS is priced at $5.28, while ACU trades at $47.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas ACU's P/E ratio is 20.81. In terms of profitability, NUS's ROE is +0.07%, compared to ACU's ROE of +0.08%. Regarding short-term risk, NUS is more volatile compared to ACU. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check ACU's competition here
NUS vs SKIN Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, SKIN has a market cap of 89.7M. Regarding current trading prices, NUS is priced at $5.28, while SKIN trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas SKIN's P/E ratio is -4.07. In terms of profitability, NUS's ROE is +0.07%, compared to SKIN's ROE of -0.09%. Regarding short-term risk, NUS is less volatile compared to SKIN. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check SKIN's competition here
NUS vs GROV Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, GROV has a market cap of 52.5M. Regarding current trading prices, NUS is priced at $5.28, while GROV trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas GROV's P/E ratio is -4.81. In terms of profitability, NUS's ROE is +0.07%, compared to GROV's ROE of -1.06%. Regarding short-term risk, NUS is less volatile compared to GROV. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check GROV's competition here
NUS vs SLSN Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, SLSN has a market cap of 51.9M. Regarding current trading prices, NUS is priced at $5.28, while SLSN trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas SLSN's P/E ratio is 59.76. In terms of profitability, NUS's ROE is +0.07%, compared to SLSN's ROE of +0.05%. Regarding short-term risk, NUS is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check SLSN's competition here
NUS vs AXIL Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, AXIL has a market cap of 45.7M. Regarding current trading prices, NUS is priced at $5.28, while AXIL trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas AXIL's P/E ratio is 55.83. In terms of profitability, NUS's ROE is +0.07%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, NUS is less volatile compared to AXIL. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check AXIL's competition here
NUS vs UG Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, UG has a market cap of 32.8M. Regarding current trading prices, NUS is priced at $5.28, while UG trades at $7.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas UG's P/E ratio is 13.73. In terms of profitability, NUS's ROE is +0.07%, compared to UG's ROE of +0.21%. Regarding short-term risk, NUS is more volatile compared to UG. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check UG's competition here
NUS vs DSY Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, DSY has a market cap of 12.7M. Regarding current trading prices, NUS is priced at $5.28, while DSY trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas DSY's P/E ratio is -0.30. In terms of profitability, NUS's ROE is +0.07%, compared to DSY's ROE of +14.77%. Regarding short-term risk, NUS is less volatile compared to DSY. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check DSY's competition here
NUS vs PHH Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, NUS is priced at $5.28, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas PHH's P/E ratio is -0.53. In terms of profitability, NUS's ROE is +0.07%, compared to PHH's ROE of +0.38%. Regarding short-term risk, NUS is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check PHH's competition here
NUS vs MTEX Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, MTEX has a market cap of 9.9M. Regarding current trading prices, NUS is priced at $5.28, while MTEX trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas MTEX's P/E ratio is -0.76. In terms of profitability, NUS's ROE is +0.07%, compared to MTEX's ROE of -23.83%. Regarding short-term risk, NUS is more volatile compared to MTEX. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check MTEX's competition here
NUS vs BRSH Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, NUS is priced at $5.28, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas BRSH's P/E ratio is -0.01. In terms of profitability, NUS's ROE is +0.07%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, NUS is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check BRSH's competition here
NUS vs TANH Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, TANH has a market cap of 2.4M. Regarding current trading prices, NUS is priced at $5.28, while TANH trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas TANH's P/E ratio is 0.04. In terms of profitability, NUS's ROE is +0.07%, compared to TANH's ROE of -0.25%. Regarding short-term risk, NUS is less volatile compared to TANH. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check TANH's competition here
NUS vs TKLF Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, TKLF has a market cap of 842.3K. Regarding current trading prices, NUS is priced at $5.28, while TKLF trades at $2.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas TKLF's P/E ratio is 33.17. In terms of profitability, NUS's ROE is +0.07%, compared to TKLF's ROE of +0.17%. Regarding short-term risk, NUS is more volatile compared to TKLF. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check TKLF's competition here
NUS vs BRSHW Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, NUS is priced at $5.28, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas BRSHW's P/E ratio is N/A. In terms of profitability, NUS's ROE is +0.07%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, NUS is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check BRSHW's competition here
NUS vs RDEN Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, NUS is priced at $5.28, while RDEN trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas RDEN's P/E ratio is -5.68. In terms of profitability, NUS's ROE is +0.07%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, NUS is more volatile compared to RDEN. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check RDEN's competition here
NUS vs GROV-WT Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, NUS is priced at $5.28, while GROV-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, NUS's ROE is +0.07%, compared to GROV-WT's ROE of -1.06%. Regarding short-term risk, NUS is more volatile compared to GROV-WT. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check GROV-WT's competition here
NUS vs REV Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, REV has a market cap of 0. Regarding current trading prices, NUS is priced at $5.28, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas REV's P/E ratio is -1.19. In terms of profitability, NUS's ROE is +0.07%, compared to REV's ROE of +0.89%. Regarding short-term risk, NUS is less volatile compared to REV. This indicates potentially lower risk in terms of short-term price fluctuations for NUS.Check REV's competition here
NUS vs SUMR Comparison July 2026
NUS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUS stands at 256.1M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, NUS is priced at $5.28, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUS currently has a P/E ratio of 4.40, whereas SUMR's P/E ratio is -3.66. In terms of profitability, NUS's ROE is +0.07%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, NUS is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for NUS.Check SUMR's competition here